PNM-CAP™
Peripheral Nerve Injury Repair
Phase 1Active
Key Facts
About Renerva
Renerva is a private, preclinical-stage medical device company focused on transformative solutions for peripheral nerve repair. Its lead investigational device, the PNM-CAP™, has received FDA IDE approval to commence a first-in-human clinical trial, marking a significant milestone. The company operates with a lean, mission-driven team from its headquarters in Pittsburgh, PA, and is backed by experienced leadership in medtech, bioengineering, and clinical nerve surgery. Renerva aims to address the significant unmet need in treating nerve injuries, which often lead to chronic pain and loss of function.
View full company profile